32 min listen
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
ratings:
Length:
31 minutes
Released:
Sep 28, 2023
Format:
Podcast episode
Description
Umoja Biopharma's CEO, Andy Scharenberg, M.D., joins Cell & Gene: The Podcast's Erin Harris to discuss the evolution of allogeneic, in vivo CAR-T cell therapeutics. They discuss The Climb, or The Colorado Laboratory and Innovation Manufacturing Building, which is Umoja’s lentiviral vector development and manufacturing facility. They also cover recent progress in lentiviral vector manufacturing.
Released:
Sep 28, 2023
Format:
Podcast episode
Titles in the series (75)
Therapeutic Firsts and "Eds and Meds" with Penn’s Dr. Bruce Levine by Cell & Gene: The Podcast